logo
Select company
Select metric
33.56%Return on Assets
VS
Market
99
Sector
99
Industry
99
History
100
$ 1.2Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 6.91M$ 2.32M33.56%
3/31/2025$ 9.87M$ 2.66M26.9%
12/31/2024$ 3.42M$ -8.61M-251.48%
9/30/2024$ 3.88M$ -16.57M-427.26%
6/30/2024$ 3.92M$ -16.11M-410.32%
3/31/2024$ 5.36M$ -18.55M-346.31%
12/31/2023$ 9.03M$ -16.7M-184.82%
9/30/2023$ 12.85M$ -15.73M-122.42%
6/30/2023$ 16.01M$ -19.77M-123.5%
3/31/2023$ 14.82M$ -17.89M-120.69%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROA stands at -74.93%.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average ROA has been -124.32%.
  • The median ROA for NOVABAY PHARMACEUTICALS INC during this period was -76.46%
  • NOVABAY PHARMACEUTICALS INC reached its highest ROA over the past 5 years at 33.56%.
  • The lowest ROA recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe -427.26%

NOVABAY PHARMACEUTICALS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
INM : INMED PHARMACEUTICALS INC -52.39%XBIO : XENETIC BIOSCIENCES INC -57.59%CNSP : CNS PHARMACEUTICALS INC -106.55%ENVB : ENVERIC BIOSCIENCES INC -280.2%CPHI : CHINA PHARMA HOLDINGS INC -26.56%GRI : GRI BIO INC -210.04%AZTR : AZITRA INC -236.6%ONCO : ONCONETIX INC -240.02%SPRB : SPRUCE BIOSCIENCES INC -221.53%REVB : REVELATION BIOSCIENCES INC -215.84%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for NOVABAY PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -12.8M ] / Assets [ $ 17.08M ]
(=) ROA [ -74.93% ]

NBY - Return on Assets, Last 5 years

-427.26%

Minimum

Sep 30, 2024

33.56%

Maximum

Jun 30, 2025

-124.32%

Average

-76.46%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.44K
min-33.4%
max33.98%
average0.12%
median1.53%
std10.61%